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In  passively  sensitized  guinea  pigs  anaphylaxis  has  been  elicited  with 
known  amounts  of antibody and  antigen  (1).  Thus,  some  information has 
been  obtained  regarding  a  quantitative  relationship  between  antigen  and 
antibody  in  the  production  of  fatal  anaphylactic  shock.  Since  sublethal 
degrees of shock do not lend  themselves to accurate and objective grading, 
little or no attempt has been made to construct dose-response  curves based 
on graded responses of the animals to graded doses of either antigen or anti- 
body. The. experiments to be presented in this paper describe  the effects of 
drugs upon a  non-fatal anaphylactic reaction for which dose-response curves 
can be constructed when graded amounts of antibody are administered. 
Feinberg and Malkiel  (2)  observed  that when passively sensitized guinea 
pigs were exposed to an aerosol of the specific antigen, the time required for 
the production of dyspnea and cough was relatively constant. They did not, 
however, determine the amount of injected antibody, nor did they administer 
graded doses.  Herxheimer (3) and Armitage et al.  (4) used a similar procedure 
with actively sensitized guinea  pigs.  In  none  of these  experiments  was  an 
objective  measure  of  the  end-point  possible.  Herxheimer  pointed  out  that 
determination of the end-point was difficult and subjective; he relied upon the 
combined judgment of two experienced observers. 
The  technique developed in this laboratory permits one  to determine ob- 
jectively and quantitatively the reaction of guinea pigs sensitized with known 
amounts of antibody and exposed to an aerosol of the specific  antigen. The 
principle  of  the  method  consists  in  obtaining by mechanical  registration a 
count of the  number of coughs produced by the animal within a  fixed ex- 
posure time. 
Methods 
Guinea pigs of both sexes, weighing 250 to 350 gin., were injected intravenously with 
known amounts of rabbit antiserum in which a determination  of antibody nitrogen  had pre- 
viously been made.  x The antigen used, both for sensitizing  the rabbits and for exposing the 
x  The authors are indebted to Dr. Morris Solotorovsky  and Dr. Curt Porter, of Merck 
Institute for Therapeutic Research,  Rahway,  New Jersey, for assistance  in this determination. 
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guinea pigs, was Armour's crystalline bovine plasma albumin. Although intracardiac  injec- 
tions are frequently  employed in guinea pigs, it is our feeling that such a procedure entails 
unnecessary risk of injury to the animal.  Contrary to the impression of many workers, in- 
travenous  injection of guinea pigs is quick and easy after some practice  (see Appendix to 
Kabat and Mayer (1)). We generally use the vein on the outer surface of the left foreleg. 
About 48 hours after  administration  of the antiserum,  the animals were exposed in in- 
dividual chambers to an aerosol of specific antigen. Exposure to the aerosol, which consisted 
of particles of 1 g or less in diameter,  induced coughing. By means of a rubber  diaphragm 
and an electric circuit  described in a previous paper  dealing with  antitussive  drugs  (5), a 
count of the number of coughs was semi-automatically obtained. 
In the present experiments, the animals were left in the chamber for 10 minutes. Severe 
anaphylactic  shock was seldom observed with this procedure; the reactions of the animals 
seldom went beyond the stage of coughing and moderate dyspnea. 
TABLE I 
E~ect of Varying the ConcentraHon  of Antigen in the Aerosolized Solution 
Guinea pigs sensitized with 80~, of antibody nitrogen, and  exposed 48 hours  later for 10 
minutes in the aerosol chamber. 
Concentration  of antigen, per cent ........  0.1 
No. of ~-~mala .........................  5 














Effect of Varying the Concentration of Antigen.--Table I  shows the results of 
employing varying concentrations of antigen in the aerosolized solution  when 
the  amount  of antibody was kept  constant  at  807  of antibody nitrogen  for 
each animal.  It was  impossible  to estimate  how much  antigen  was  actually 
absorbed by the animal, so no attempt was made to establish a  dose-response 
relationship.  Rather,  the results of this experiment were used to establish  the 
concentration of antigen  to be used in later experiments.  It is clear that 0.1 
per cent gives a  submaximal response,  while a  maximal effect is obtained by 
concentrations  of 0.2  to  1 per  cent or above.  For routine  use  in further  ex- 
periments,  the  1 per cent solution was adopted. 
Dose-response Curve for Antibody Nitrogen.--With  doses of antibody nitro- 
gen between  20 and 807,  the number of coughs produced by the animal in a 
10 minute exposure was found to be linearly related  to log dose. An analysis 
of the data is presented in Table II. These are pooled results from five experi- 
ments, with 5 to 6 animals per group in each experiment; the lowest dose, 107 
of antibody N, was tested in only two of the experiments.  When the responses 
of  107  of antibody  nitrogen  were  included  in  the  statistical  analysis,  they 
were found to be non-linear with respect to log dose. However, in the range of 
207  to  807,  there  was no deviation  from linearity;  this  range  has  therefore 
been used for the statistical  analysis shown in Table II. The analysis demon- CHARLES A.  WINTER AND LARS FLATAKER  19 
strates a  very highly significant correlation between individual responses and 
log dose (coefficient of correlation, 0.56, P  <  <0.01). There was considerable 
variation  in  the  regression  coefficients of  the  individual experiments  (range, 
25.0 to 42.5) but the differences were not statistically significant.  ~ 
Fig.  1  shows  the  mean  regression  for  these  data,  and  the  points  are  the 
group averages for the individual experiments. 
TABLE II 
Dose-Response Rdationship  between A ntibody Nitrogen and Number of Coughs 
Guinea pigs sensitized with varying amounts of antibody 48 hours prior to exposure for 
10 minutes in the aerosol chamber. Concentration of aerosolized  solution: 0.2 per cent to 1 
per cent antigen. 
Antibody nitrogen, T ....................  10  20  40  80 
No. of animals  ..........................  [  12  28  27  28 
Mean No. of coughs .....................  2.17  7.29  17.30  27.36 
-4- standard error ........................  -4-1.24  :/:1.20  -4-2.28  -4-3.13 
Analysis of ~ariance, 20, 40, and 80y 
Source of variation  Degrees of  Sum of  Mean square 
freedom  squares 
Total .......................................  82  17,812 
Within groups (error) .........................  80  12,172  152 
Doses antibody N ............................  2  5,640  2,820 
Linear regression .............................  1  5,640 
Deviations from linear regression  ..............  I  0  0 
2820 
F  =  --  --  18.55 very highly significant. 
152 
Standard deviation of single determination =  12.33. 
Regression equation: Y =  33.45 log X  -- 36.21, in which Y -- No. of coughs,  X  -- 'y anti- 
body N. 
Index of precision (lambda) -- 12.33/33.45  =  0.37. 
Specificity of the Reaction.--Two groups of non-sensitized control animals, 5 
animals per group, were exposed to the aerosolized antigen. In one group, one 
animal coughed once, and in the other group one animal coughed three times 
during a  10 minute exposure.  In each group, 4  of the animals had no coughs. 
Therefore,  when a  significant number of  coughs  was  produced  in  sensitized 
animals, it was considered to be a  specific response. 
Two of these experiments were performed with antiserum kindly supplied by Dr. Joaquln 
Munoz, of Sharp & Dohme, Division of Merck & Co.,  Inc., West Point, Pennsylvania. The 
other three were performed with  antiserum prepared  in our own laboratories. The results 
with the two antisera were  identical. 20  COUGH  IN  SENSITIZED  GUINEA  PIGS 
Effect  of Antitussive  Drugs.--The  cough produced by this  technique does 
not respond to the antitussive  drug,  codeine, but can be inhibited  by anti- 
allergic agents,  such  as antihistaminic  drugs  and  cortisone (see below).  We 
have  shown  elsewhere  (5)  that  when  guinea  pigs  are  exposed in  the  glass 
chambers to a simple irritant such as ammonia or aerosolized dilute acid, they 
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Fzo. 1 Dose-response curve showing the relationship between log dose of antibody and 
the number of coughs. Guinea pigs were passively sensitized 48 hours before exposure to 
aerosolized 1 per cent antigen solution for 10 minutes. Solid line, untreated controls, pooled 
data from 5 experiments. The points are group averages, 5 to 6 animals per group. 
TABLE III 
E.~ect of Antltu~sire Drugs upon the Cough 
Guinea pigs sensitized with 803, of antibody nitrogen and exposed for 10 minutes to aero- 
solized antigen. 6 animals per group. 








No. of coughs 
Narcotine  Codeine PO. 
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respond  by  a  cough  which  is  readily  inhibited  by  such  drugs  as  codeine, 
morphine, propadrine,  and narcotine. These drugs are effective in  doses on 
the order of 0.5 to 1 rag. per kg. against cough produced by simple irritants. 
Table  III  shows  the  results  of three  experiments with  antitussive drugs  in 
the cough produced by the present technique in sensitized guinea pigs.  It is 
clear that narcotine  was the only antitussive drug effective in this test, even 
though both codeine and propadrine were used at higher dose levels. CHARLES  A.  WINTER  AND  LARS  :FLATAKER  21 
Since  the  antihistaminic  drug,  pyrilamine  maleate,  is  very  effective  in 
inhibiting  the  cough of the  sensitized animals (see below),  it was of interest 
to determine whether narcotine possessed antihistaminic activity. Six animals 
were injected  with  10  rag.  per kg.  of narcotine,  and  an  equal  number with 
0.1  rag. per kg.  of pyrilamine maleate. They were then exposed to histamine 
aerosol  in  the  same  chambers.  All  of  the  narcotine-treated  animals  suffered 
severe histamine  shock  within  an  average of  1.5  minutes  of exposure,  com- 
parable  to  the  average  of  2.1  minutes  for  uninjected  controls.  All  of  the 
pyrilamine-treated  animals  survived  10  minutes  of  exposure  without  severe 
shock.  Narcotine showed no trace of antihistaminic activity, although  it was 
TABLE  IV 
Synergls~ic l~ect of Cortisone and Pyrilamine in Inhibiting Cough 
Guinea pigs sensitized with 807 of antibody N and exposed for 10 minutes to aerosollzed 
antigen, 1 per cent solution. 6 animals per group. 
Treatment* 
Pyrilamine ..................... 
Cortisone  ...................... 
Pyrilamine  -{- cortisone  ......... 
Controls  ...................... 
Mean No. of coughs 
Experiment 1  Experiment 2 
9.5  7.8 
14.7  3.3 
<o.2~  o 
22.6  14.8 
Mean latent period 
Experiment 1  Experiment 2 
mln.  mln. 
6.12  6.21 
7.67  7.97 
>1o  >1o 
2.55  3.33 
* Subcutaneous injections: pyrilamine maleate (neo-antergan, Merck) 10T/kg. 1 hour be- 
fore exposure; cortisone acetate (Cortone, Merck) 5 rag. daily for 3 days, last dose 24 hours 
before exposure. 
~: One animal gave 1 cough. 
administered in a  dose ten  times as great as that which  was found to be ef- 
fective in the sensitized animals. 
In additional  experiments, neither cortisone acetate nor the antihistaminic 
drugs,  phenergan hydroch]oride and pyrilamine ma]eate, inhibited  the  cough 
owing to a  simple irritant.  For example, one group of 7 animals, after receiv- 
ing 5 mg. daily of cortisone acetate for 3  days, gave 73.4 4- 9.7  coughs when 
exposed to ammonia vapor in the chamber for 3 minutes. This did not differ 
significantly from the  figure of 54.1  ±  6.6  obtained in  a  control  group of  7 
animals. Another group of 6 animals exposed to ammonia vapor for 3 minutes 
gave an average of 49.8 coughs before injection of 8 mg. per kg. of pyrilamine 
maleate,  and  49.2  coughs  1  hour  after injection;  corresponding figures for a 
group observed on the same day and treated with  1 rag. per kg.  of narcotine 
were 54.8 and  14.6.  Narcotine is therefore unique among the drugs tested, in 
that it inhibits both types of cough. 
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injection  of 103' per kg. of pyrilamine maleate (neo-antergan)  1 hour prior  to 
exposure  in  the  chamber  markedly  inhibited  the  coughing  response  to 
aerosolized antigen in the sensitized animals (Table  IV). Increasing the dose 
of antihistaminic drug did not increase its effectiveness. For example, in  one 
experiment,  3  groups  of animals sensitized  with 803, of antibody  nitrogen 
were given 5, 10, and 10003, per kg., respectively, of pyrilamine maleate. The 
mean number of coughs obtained was 22.6, 11.8, and 8.5, respectively.  The 
first group did not differ significantly  from the controls  (32.7) and the last 
two groups did not differ significantly from each other. 
On the other hand, Table IV demonstrates that the inhibiting effect of 10~ 
per kg.  of antihistaminic drug can be augmented by prior  treatment with 
cortisone. This table shows two identical experiments on groups of 6  animals, 
sensitized  with 80"r of antibody nitrogen.  Cortisone  was administered  sub- 
cutaneously, 5 rag. daily for 3 days, with exposure in the chamber on the 4th 
day. Not only were the coughs counted,  but the times required  for the first 
bout of coughing to occur was also measured. Some of the treated animals did 
not show a dear-cut bout of coughing. For purposes of calculating  the mean 
latent period, such animals were arbitrarily assigned a time of 10 minutes. 
Either cortisone or pyrilamine reduced the number of coughs and prolonged 
the latent period, but neither treatment completely suppressed  the reaction. 
When  pyrilamine was  administered  to  animals  pretreated  with  cortisone, 
inhibition was complete. Not only was there no cough in these animals,  but 
other signs of reaction,  such as hyperpnea, dyspnea, and restlessness were also 
notab]y absent. 
This effect of cortisone is in contrast to the failure of this steroid to inhibit 
fatal  anaphylactic shock  due  to  intravenous antigen  (references  in  Soloto- 
rovsky and Winsten (6)). We can confirm the latter observation,  using  the 
same antigen-antibody system as was used in the coughing experiments. Eight 
guinea pigs were treated for 5 days with 5 rag. of cortisone daily. On the 4th 
day, 803, of antibody nitrogen was injected,  and on the 6th day,  1 rag.  of 
antigen was administered intravenously. Six of the 8 animals died in anaphy- 
lactic shock, one had severe shock but recovered,  while one had mild shock. 
By contrast, 6 anima]s were similarly sensitized and given the same shocking 
injection on the same day, but were pretreated with 1 mg. per kg. of pyrila- 
mine maleate 1 hour before  shocking.  None of these animals suffered more 
than very mild signs of shock. 
DISCUSSION 
Perhaps the principal  advantage of this technique is the fact that for the 
first time a graded response has been found in sensitized animals which can be 
objectively measured with  sufficient  precision  to  show  that a  quantitative 
relationship  exists between the degree of response and the amount of antibody 
injected.  The  method  would  be  even  more  useful  if  a  similarly  precise CHARLES  A.  WINTER  AND  LAPS  FLATAKER  23 
measurement could be made of the amount of antigen which entered into the 
reaction,  and  also if the linear  relationship  extended over a  wider range  of 
doses of antibody. 
It is d  interest that the cough produced by this procedure responds to the 
same sort  of drugs which are of therapeutic  value in human  allergy  (anti- 
histaminic  agent  and  cortisone)  but is  unaffected by the antitussive  drug, 
codeine. Codeine is generally thought to act by central inhibition of the cough 
reflex, and it is quite effective in suppressing the cough of guinea pigs pro- 
duced by simple irritants administered in the same way as was the antigen in 
the present experiments.  It is not known whether the "allergic" cough pro- 
duced in this procedure is due to an irritating  effect of the products of the 
antigen-antibody reaction, or whether the stimulus for the cough is related to 
the degree of bronchoconstriction which  probably occurs when the sensitized 
guinea pig is exposed to the inhaled antigen.  It is evident, however, that the 
reaction produces such a strong stimulus to the cough reflex that the central 
inhibiting effect of codeine in doses eight times as great as the amount neces- 
sary to have a definite inhibiting effect on cough due to simple  irritants had 
no trace of effect upon it. The activity of narcotine is also surprising,  since it 
has no antihistaminic  activity, and  since  the other antitussive drugs  tested 
were ineffective.  The mechanism  of action of narcotine  in  this procedure is 
not known, but it might be interesting to test this drug for anti-allergic  ac- 
tivity  in  man.  In  this  connection,  it  may  be  noted  that  Bickerman  and 
Barach (7) found narcotine to be particularly effective against experimentally 
induced cough in asthmatic subjects. 
It  is  probable  that  cortisone  is  effective in  this  system by virtue  of  its 
general  anti-inflammatory action, and that pyrilamine is active because of its 
antagonism  to the peripheral  effects of histamine  and/or  other noxious  sub- 
stances  released  by the  antigen-antibody  reaction  in  the  respiratory  tract. 
Both cortisone and pyriiamine would therefore hinder the development of the 
local tissue reaction responsible  for the initiation of the cough reflex. There is 
a  marked contrast between the ability of cortisone to inhibit the reaction in 
the present experimental system and its failure to affect anaphylactic shock 
produced by injected antigen. Narcotine in our hands (unpublished data) also 
is relatively ineffective  in the treatment of fatal anaphylactic shock in guinea 
pigs.  It is likely that  intravenous antigen releases  so much histamine  that a 
potent antihistaminic  drug is required  to control shock.  Factors other than 
histamine are of sufficient importance in the genesis of the cough that control 
may be obtained by anti-allergic  agents not possessing antihistaminic activity. 
The activity of cortisone in  these experiments parallels  its action in human 
asthma rather than in fatal anaphylaxis.  It does not necessarily follow that 
either the antigen-antibody  system  used in these investigations,  or  the type 
of local reaction obtained, is the same as that seen in asthma in humans. 
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in these experiments.  A degree of inhibition of the reaction was obtained with 
the antihistaminic  drug in animals pretreated with cortisone which could not 
be achieved  by greatly  increasing  the  dose of  antihistaminic  agent  alone. 
Whether this observation has any clinical significance remains to be seen. 
SUM~,RY 
A technique is described for measuring objectively and quantitatively the 
reaction  of  sensitized  guinea  pigs  when  exposed  to  an  aerosol  of  specific 
antigen.  The principle involves registration by semi-automatic means of the 
number  of  coughs  produced  in  animals  passively  sensitized  with  known 
amounts of antibody. The number of coughs is shown to be linearly related to 
log  dose of antibody  within  a  limited  range  and  a  dose-response  curve  is 
presented. 
The cough produced by this procedure is not inhibited by the antitussive 
drugs,  codeine  and propadrine,  but can be inhibited by anti-aUergic  agents, 
such as cortisone and an antihistaminic drug. It is also inhibited by narcotine. 
The last is the only compound so far tested which suppresses both the cough 
produced by this procedure and that produced by a simple irritant. 
The action of cortisone and the antihistaminic drug, pyrilamine, is shown to 
be synergistic.  A small  dose of pyrilamine in animals  pretreated with corti- 
sone gives a  degree of inhibition which cannot be obtained by increasing  the 
dose of pyrilamine in animals not treated with cortisone. 
BIBLIOGRAPHY 
1. Kabat, E. A., and Mayer, M. M., Experimental Immunochemistry, Springfield, 
Illinois, Charles C. Thomas,  1948. 
2.  Feinberg, S. M., and Malkiel, S., Proc. Soc. Exper. Biol. and Med., 1952, 81,104. 
3. Herxheimer,  H.,  J.  Physiol.,  1952, 117, 251. 
4.  Armitage, P., Herxheimer, H., and Rosa, L., Brit. J. Pharmacol., 1952, 7, 625. 
5. Winter, C. A., and Flataker, L., J'. Pharmacol. and Exp. Therap., 1954, 112, 99. 
6.  Solotorovsky, M., and Winsten, S., J. Immunol.,  1954, 72,  177. 
7. Bickerman, H. A., and Barach, A. L., Am. J. Med. Sc.,  1954, 228, 156. 